Defining the ‘exhausted’ T cells that respond to PD1 checkpoint blockade

被引：0
|
作者：
Yvonne Bordon
机构：
[1] Nature Reviews Immunology,
来源：
Nature Reviews Immunology | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
MYB-dependent precursors of exhausted T cells show stem-like properties and mediate the response to PD1 immune checkpoint blockade.
引用
收藏
页码：593 / 593
相关论文
共 50 条
  • [31] Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade (vol 20, pg 326, 2019)
    Miller, Brian C.
    Sen, Debattama R.
    Al Abosy, Rose
    Bi, Kevin
    Virkud, Yamini V.
    LaFleur, Martin W.
    Yates, Kathleen B.
    Lako, Ana
    Felt, Kristen
    Naik, Girish S.
    Manos, Michael
    Gjini, Evisa
    Kuchroo, Juhi R.
    Ishizuka, Jeffrey J.
    Collier, Jenna L.
    Griffin, Gabriel K.
    Maleri, Seth
    Comstock, Dawn E.
    Weiss, Sarah A.
    Brown, Flavian D.
    Panda, Arpit
    Zimmer, Margaret D.
    Manguso, Robert T.
    Hodi, F. Stephen
    Rodig, Scott J.
    Sharpe, Arlene H.
    Haining, W. Nicholas
    NATURE IMMUNOLOGY, 2019, 20 (11) : 1556 - 1556
  • [32] PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
    West, Erin E.
    Jin, Hyun-Tak
    Rasheed, Ata-Ur
    Penaloza-MacMaster, Pablo
    Ha, Sang-Jun
    Tan, Wendy G.
    Youngblood, Ben
    Freeman, Gordon J.
    Smith, Kendall A.
    Ahmed, Rafi
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06): : 2604 - 2615
  • [33] PD-1 BLOCKADE-MEDIATED RESCUE OF EXHAUSTED T CELLS REQUIRES CD28
    Hui, E.
    Cheung, J.
    Zhu, J.
    Su, X.
    Taylor, M. J.
    Wallweber, H. A.
    Kamphorst, A. O.
    Wieland, A.
    Nasti, T.
    Yang, S.
    Zhang, R.
    Barber, D. L.
    CANCER DISCOVERY, 2017, 7 (05) : 453 - 453
  • [34] Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
    Blackburn, Shawn D.
    Shin, Haina
    Freeman, Gordon J.
    Wherry, E. John
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (39) : 15016 - 15021
  • [35] T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy
    Bruns, Michael
    Wanger, Jara
    Schumacher, Udo
    Deppert, Wolfgang
    ONCOTARGET, 2016, 7 (40) : 64543 - 64559
  • [36] Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade
    Snook, Jeremy P.
    Soedel, Ashleigh J.
    Ekiz, H. Atakan
    O'Connell, Ryan M.
    Williams, Matthew A.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 506 - 517
  • [37] Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy with PD1 Checkpoint Blockade
    Fang, L.
    Ly, D.
    Liu, W.
    Wang, S.
    Lee, J.
    Kang, H.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S525 - S526
  • [38] PD1 blockade augments adoptive T cell therapy via endogenous T cells rather than direct enhancement of transferred T cells
    Davies, John S.
    Karimipour, Farrah
    Zhang, Ling
    Serna, Carylinda
    Hinrichs, Christian
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [39] Resistance to PD1/PDL1 checkpoint inhibition
    O'Donnell, Jake S.
    Long, Georgina V.
    Scolyer, Richard A.
    Teng, Michele W. L.
    Smyth, Mark J.
    CANCER TREATMENT REVIEWS, 2017, 52 : 71 - 81
  • [40] PD1 blockade augments adoptive T cell therapy via endogenous T cells rather than direct enhancement of transferred T cells
    Davies, John
    Karimipour, Farrah
    Zhang, Ling
    Serna, Carylinda
    Hinrichs, Christian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345